Sale!

TPP1 Gene Spinocerebellar Ataxia Type 7 Autosomal Recessive Genetic Test

Original price was: $700.Current price is: $500.

-29%

The TPP1 Gene Spinocerebellar Ataxia Type 7 Autosomal Recessive NGS Genetic DNA Test is a comprehensive diagnostic tool designed to identify mutations in the TPP1 gene associated with spinocerebellar ataxia type 7. This advanced genetic test utilizes Next Generation Sequencing technology to provide precise detection of autosomal recessive inheritance patterns. The test is crucial for individuals experiencing progressive neurological symptoms including coordination difficulties, vision problems, and movement disorders. Results typically take 3-4 weeks and require either blood samples, extracted DNA, or blood spots on FTA cards. Genetic counseling and clinical history documentation are essential pre-test requirements. The test is available for $500 USD (discounted from $700 USD) and provides valuable information for treatment planning and family genetic risk assessment.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

TPP1 Gene Spinocerebellar Ataxia Type 7 Autosomal Recessive NGS Genetic DNA Test

Comprehensive Genetic Testing for Neurological Disorders

The TPP1 Gene Spinocerebellar Ataxia Type 7 Autosomal Recessive NGS Genetic DNA Test represents a cutting-edge diagnostic approach for identifying genetic mutations responsible for spinocerebellar ataxia type 7. This specialized neurological genetic test utilizes advanced Next Generation Sequencing (NGS) technology to provide comprehensive analysis of the TPP1 gene, which plays a critical role in neurological function and coordination.

What This Test Measures and Detects

This sophisticated genetic test specifically targets mutations in the TPP1 gene that are associated with spinocerebellar ataxia type 7, an autosomal recessive neurological disorder. The test examines:

  • Complete sequencing of the TPP1 gene using NGS technology
  • Identification of pathogenic variants and mutations
  • Autosomal recessive inheritance pattern analysis
  • Detection of both known and novel genetic variations
  • Comprehensive mutation profiling for accurate diagnosis

Who Should Consider This Test

This genetic test is recommended for individuals experiencing symptoms suggestive of spinocerebellar ataxia or those with a family history of neurological disorders. Key indications include:

  • Progressive coordination difficulties and balance problems
  • Unsteady gait and walking abnormalities
  • Speech difficulties and slurred speech patterns
  • Vision problems including retinal degeneration
  • Family history of autosomal recessive neurological conditions
  • Unexplained movement disorders in childhood or adulthood
  • Progressive neurological symptoms without clear diagnosis

Benefits of Genetic Testing

Undergoing the TPP1 gene test provides numerous advantages for patients and healthcare providers:

  • Accurate Diagnosis: Provides definitive identification of genetic causes for neurological symptoms
  • Treatment Guidance: Helps neurologists develop targeted treatment strategies
  • Family Planning: Offers crucial information for genetic counseling and family planning decisions
  • Early Intervention: Enables early management of symptoms and proactive care
  • Peace of Mind: Reduces uncertainty and provides clarity about neurological conditions
  • Research Contribution: Contributes to ongoing neurological genetic research

Understanding Your Test Results

Our comprehensive genetic counseling services help patients understand their test results:

  • Positive Result: Indicates the presence of TPP1 gene mutations associated with spinocerebellar ataxia type 7
  • Negative Result: Suggests no detectable mutations in the TPP1 gene, though other genetic causes may exist
  • Variant of Uncertain Significance: Some genetic variations may require additional family studies
  • Carrier Status: Identifies individuals who carry one copy of the mutated gene

All results are accompanied by detailed explanations from our certified genetic counselors to ensure complete understanding and appropriate next steps.

Test Information and Pricing

Test Component Details
Test Name TPP1 Gene Spinocerebellar Ataxia Type 7 Autosomal Recessive NGS Genetic DNA Test
Discount Price $500 USD
Regular Price $700 USD
Turnaround Time 3 to 4 Weeks
Sample Type Blood, Extracted DNA, or One Drop Blood on FTA Card
Specialty Neurology
Department Genetics
Testing Method Next Generation Sequencing (NGS) Technology

Nationwide Accessibility

We have diagnostic centers conveniently located throughout the United States, serving patients in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many other cities. Our network ensures that comprehensive genetic testing is accessible to patients nationwide.

Take the Next Step Toward Clarity

If you or a loved one are experiencing neurological symptoms or have concerns about genetic neurological conditions, our TPP1 Gene Spinocerebellar Ataxia Type 7 test provides the answers you need. Our team of genetic specialists and neurologists are ready to guide you through the testing process and help you understand your results.

Call or WhatsApp us today at +1(267) 388-9828 to schedule your genetic counseling session and book your test. Take control of your neurological health with definitive genetic testing from America’s leading genetics laboratory.